Nirsevimab slashes RSV hospitalizations in infants by 78% in real-world study A Spanish study found that nirsevimab prophylaxis significantly reduced infant hospitalizations, ICU admissions, and severe symptoms linked to RSV and other respiratory viruses. Hospitalizations for R...

Nirsevimab slashes RSV hospitalizations in infants by 78% in real-world study 🇪🇸🧬👶 www.news-medical.net/news/2025050... #RSV #nirsevimab #infanthealth #pediatrics #bronchiolitis #monoclonalantibodies #hospitalization #publichealth #viralprotection #Spain @isirvepi.bsky.social